2018 Jack Yardley Investigator Award
Congratulations to Dr. Rhonda K. Yantiss, recipient of the 2018 Jack Yardley Investigator Award!
2018 Harvey Goldman Lifetime Achievement Award
Congratulations to Dr. Frank A. Mitros, recipient of the 2018 Harvey Goldman Lifetime Achievement Award! Please click here for a press release from University of Iowa Healthcare.
Congratulations to the 2018 GIPS Abstract Award and Travel Award Winners!
Abstract Award Winner:
Odise Cenaj, Brigham and Women’s Hospital: Detection of ERBB2 Amplification by Next Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma
Abstract Award Runners-up:
Phoenix Bell, University of Rochester Medical Center: Significance of Clinicopathologic Parameters, Including Margin Distance and Tumor Budding, on Local Disease Recurrence Following Esophageal Endoscopic Mucosal Resection
Runner-Up: Kwun Wah Wen, University of California, San Francisco: “Indefinite for Dysplasia” in Inflammatory Bowel Disease: Aneuploidy as a Diagnostic and Prognostic Marker of High-Grade Dysplasia or Colorectal Cancer
Travel Award Winner:
Ayesha S. Siddique, Hartford Hospital
GIPS at DDW 2018
DDW: June 2-5, 2018, at the Walter E. Washington Convention Center in Washington, DC
DDW Clinical Symposium: The Rodger Haggitt Gastrointestinal Pathology Society Symposium: Understanding your Pathology Report and what to do next: challenging topics and their clinical relevance
June 3, 2:00-3:30PM
Location: 151 B- Convention Center
Session number: 2460
Moderator: Dr. Maria Westerhoff
Speakers: Wendy Frankel, Rebecca Wilcox, Eric Swanson
- Wendy Frankel (with Peter Stanich): Challenges in Colorectal Cancer Microsatellite Instability
- Objectives:
- To review microsatellite instability in colorectal cancer
- To understand the importance of clear reporting in Lynch Syndrome screening
- To know the importance of communication between pathologists and gastroenterologists
- Objectives:
- Rebecca Wilcox (with Eric Ganguly): GI biopsies in the era of immunotherapy
- Objectives:
- Define immune checkpoint inhibitors and summarize their current use in gastroenterology oncology.
- Recognize and manage the unique checkpoint inhibitor side-effects, so-called immune-related adverse events (irAE).
- Specifically identify histopathology features of checkpoint inhibitor related colitis.
- Objectives:
- Eric Swanson (with Priyanka Kanth): Polyps in Cowden’s Disease
- Objectives:
- Describe the diagnostic features of an intramucosal lipoma and how to differentiate from its mimics.
- Understand the significance of an intramucosal lipoma found during colonoscopy.
- Recognize the clinical criteria for a diagnosis of Cowden syndrome.
- Objectives:
GIPS at CAP 2018
CAP: October 21-24, 2018, at the Chicago Hyatt Regency in Chicago, Illinois
Monday, October 22, 2018, 2:00-4:00 PM
S1882 Applying the New AJCC Staging System to Daily Diagnostic Practice: Gastrointestinal Pathology
2.0 CME CREDITS
This Rodger C. Haggitt GI Pathology Society session is an evidence-based update on the new AJCC staging system, specifically with regards to gastrointestinal neoplasms. It will address critical changes that been made to staging parameters and how to apply them to daily diagnostic practice. The course has a didactic component, followed by case presentations that illustrate and reinforce key points. The faculty will explain and demonstrate how to recognize important or challenging pathologic aspects of GI cancers as relevant to the updated cancer staging system and how pathologists will impact the patient’s management. There will be ample time for questions, and discussion between the presenters and participants will be encouraged. The course is intended for practicing surgical pathologists as well as residents and fellows.
You will learn to:
• Identify new staging parameters in gastrointestinal tumors
• Recognize strengths and weaknesses of the evidence behind the changes in staging parameters
• Accurately diagnose pathological aspects of gastrointestinal tumors that may impact clinical management, such as proper grossing, margin assessment, and other staging components
• Identify the latest clinical treatments of GI tumors
Faculty
Amitabh Srivastava, MBBS, FCAP
Hanlin L. Wang, MD, PhD